1 Min Read
May 4 (Reuters) - Contravir Pharmaceuticals Inc
* Contravir pharmaceuticals - contravir to advance second-generation formulation of tenofovir exalidex for treatment of hepatitis b virus (hbv) Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.